RXDX Price Targets and Analyst Ratings NASDAQ:RXDX
RXDX Forecast. What You Should Know.
RXDX Historical Ratings and Targets
About Prometheus Biosciences Inc
Prometheus Biosciences, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of novel therapeutics and companion diagnostics products for the treatment of inflammatory bowel diseases (IBD). Its lead product includes PRA023, a humanized IgG1 monoclonal antibody (mAb), which is in Phase IIa clinical trial for the treatment of ulcerative colitis and Crohn's disease, as well as systemic sclerosis-associated ... Read more
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.